Literature DB >> 12424440

Fibroblast growth factor receptor 3 mutations in achondroplasia and related forms of dwarfism.

William A Horton1, Gregory P Lunstrum.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12424440     DOI： 10.1023/a:1020914026829

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN： 1389-9155            Impact factor:   6.514


× No keyword cloud information.
  44 in total

Review 1.  Cell signaling by receptor tyrosine kinases.

Authors:  J Schlessinger
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

Review 2.  FGFs, heparan sulfate and FGFRs: complex interactions essential for development.

Authors:  D M Ornitz
Journal:  Bioessays       Date:  2000-02       Impact factor: 4.345

3.  Signal transduction pathway of human fibroblast growth factor receptor 3. Identification of a novel 66-kDa phosphoprotein.

Authors:  M Kanai; M Göke; S Tsunekawa; D K Podolsky
Journal:  J Biol Chem       Date:  1997-03-07       Impact factor: 5.157

4.  Skeletal dysplasia and defective chondrocyte differentiation by targeted overexpression of fibroblast growth factor 9 in transgenic mice.

Authors:  S Garofalo; M Kliger-Spatz; J L Cooke; O Wolstin; G P Lunstrum; S M Moshkovitz; W A Horton; A Yayon
Journal:  J Bone Miner Res       Date:  1999-11       Impact factor: 6.741

5.  Activation of Stat1 by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism.

Authors:  W C Su; M Kitagawa; N Xue; B Xie; S Garofalo; J Cho; C Deng; W A Horton; X Y Fu
Journal:  Nature       Date:  1997-03-20       Impact factor: 49.962

6.  Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4.

Authors:  K C Hart; S C Robertson; M Y Kanemitsu; A N Meyer; J A Tynan; D J Donoghue
Journal:  Oncogene       Date:  2000-07-06       Impact factor: 9.867

7.  Mutations in fibroblast growth-factor receptor 3 in sporadic cases of achondroplasia occur exclusively on the paternally derived chromosome.

Authors:  D J Wilkin; J K Szabo; R Cameron; S Henderson; G A Bellus; M L Mack; I Kaitila; J Loughlin; A Munnich; B Sykes; J Bonaventure; C A Francomano
Journal:  Am J Hum Genet       Date:  1998-09       Impact factor: 11.025

8.  Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia.

Authors:  M C Naski; Q Wang; J Xu; D M Ornitz
Journal:  Nat Genet       Date:  1996-06       Impact factor: 38.330

9.  Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia.

Authors:  M K Webster; D J Donoghue
Journal:  EMBO J       Date:  1996-02-01       Impact factor: 11.598

10.  Fibroblast growth factor receptor (FGFR) 3. Alternative splicing in immunoglobulin-like domain III creates a receptor highly specific for acidic FGF/FGF-1.

Authors:  A T Chellaiah; D G McEwen; S Werner; J Xu; D M Ornitz
Journal:  J Biol Chem       Date:  1994-04-15       Impact factor: 5.157
View more
  7 in total

1.  Sprouty 2 disturbs FGFR3 degradation in thanatophoric dysplasia type II: a severe form of human achondroplasia.

Authors:  Changsheng Guo; Catherine R Degnin; Melanie B Laederich; Gregory P Lunstrum; Paul Holden; Jeanie Bihlmaier; Deborah Krakow; Yoon-Jae Cho; William A Horton
Journal:  Cell Signal       Date:  2008-04-10       Impact factor: 4.315

Review 2.  FGF signaling in the developing endochondral skeleton.

Authors:  David M Ornitz
Journal:  Cytokine Growth Factor Rev       Date:  2005-04-01       Impact factor: 7.638

3.  An expressed fgf4 retrogene is associated with breed-defining chondrodysplasia in domestic dogs.

Authors:  Heidi G Parker; Bridgett M VonHoldt; Pascale Quignon; Elliott H Margulies; Stephanie Shao; Dana S Mosher; Tyrone C Spady; Abdel Elkahloun; Michele Cargill; Paul G Jones; Cheryl L Maslen; Gregory M Acland; Nathan B Sutter; Keiichi Kuroki; Carlos D Bustamante; Robert K Wayne; Elaine A Ostrander
Journal:  Science       Date:  2009-07-16       Impact factor: 47.728

4.  Gain-of-function mutation in FGFR3 in mice leads to decreased bone mass by affecting both osteoblastogenesis and osteoclastogenesis.

Authors:  Nan Su; Qidi Sun; Can Li; Xiumin Lu; Huabing Qi; Siyu Chen; Jing Yang; Xiaolan Du; Ling Zhao; Qifen He; Min Jin; Yue Shen; Di Chen; Lin Chen
Journal:  Hum Mol Genet       Date:  2010-01-06       Impact factor: 6.150

Review 5.  Understanding developmental mechanisms in the context of osteoarthritis.

Authors:  Peter M van der Kraan
Journal:  Curr Rheumatol Rep       Date:  2013-06       Impact factor: 4.592

6.  Dual Therapeutic Action of a Neutralizing Anti-FGF2 Aptamer in Bone Disease and Bone Cancer Pain.

Authors:  Ling Jin; Yosuke Nonaka; Shin Miyakawa; Masatoshi Fujiwara; Yoshikazu Nakamura
Journal:  Mol Ther       Date:  2016-08-10       Impact factor: 11.454

7.  Whole-body and segmental analysis of body composition in adult males with achondroplasia using dual X-ray absorptiometry.

Authors:  David Sims; Gladys Onambélé-Pearson; Adrian Burden; Carl Payton; Christopher Morse
Journal:  PLoS One       Date:  2019-03-19       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.